London Report: FTSE pares back losses after RSA and Glaxo rally February 5, 2014 THE UK’S top top equity index snapped a five-day losing streak yesterday, lifted by rallies in insurer RSA and pharma group GlaxoSmithKline. Shares in RSA rose 4.6 per cent on expectations its new chief executive Stephen Hester, credited with salvaging RBS, would help turn around the insurer, which is struggling with a £200m pound ($330m) [...]
Sales boost for drugs giant GlaxoSmithKline October 28, 2005 Drugs giants GlaxoSmithKline and AstraZeneca unveiled big rises in sales yesterday with demand for key drugs soaring. GlaxoSmithKline, the larger of the two, said sales of its asthma product Advair and Avandia for diabetes increased 20 per cent and 22 per cent respectively. The British company, whose market capitalisation is £83bn, has seen sales in [...]
Killing the cure October 28, 2005 Some say British drugs companies should be able to profit in order to reinvest in newer drugs for the greater good. Some say their profits come on the back of scientific fraud. It is perhaps one of the great puzzles of British business. As a nation we spend less on medicines than our European neighbours, [...]